Literature DB >> 29710537

Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer.

Wang Yong1, Xuan Zhuoqi1, Wang Baocheng1, Zhang Dongsheng1, Zhang Chuan1, Sun Yueming2.   

Abstract

Previous studies have revealed that miRNAs and lncRNAs participate in the pathogenesis of colorectal cancer (CRC); however, whether circular RNAs (circRNAs) are also involved remains unclear. In the present study, qRT-PCR was used to examine the expression of hsa_circ_0071589, miR-600, and enhancer of zeste homolog 2 (EZH2) in CRC. MTT assay, colony formation assay, transwell assay, and wound-healing assay were performed to assess the effects of hsa_circ_0071589, miR-600, and EZH2 on CRC cell viability, proliferation, invasion, and migration. Bioinformatics analysis, luciferase reporter assay, and RIP assay were used to explore the correlations among hsa_circ_0071589, miR-600, and EZH2 expression in CRC cells. The results showed that hsa_circ_0071589 expression was significantly higher in CRC tissues than in normal tissues. Blockage of hsa_circ_0071589 in CRC cells inhibited tumor growth, invasion and migration. Hsa_circ_0071589 was able to promote the expression of EZH2 by acting as a sponge of miR-600. In addition, miR-600 expression was negatively correlated to hsa_circ_0071589 expression in CRC tissues. These results demonstrated that the hsa_circ_0071589/miR-600/EZH2 axis may play critical regulatory roles in the pathogenesis of CRC and may serve as a novel therapy target in CRC.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; EZH2; Invasion; Migration; Proliferation; hsa_circ_0071589; miR-600

Mesh:

Substances:

Year:  2018        PMID: 29710537     DOI: 10.1016/j.biopha.2018.03.085

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

1.  Hsa_circ_0001550 facilitates colorectal cancer progression through mediating microRNA-4262/nuclear casein kinase and cyclin-dependent kinase substrate 1 cascade.

Authors:  Ying Zhou; Qilin Zhang; Xiaofeng Qiu; Tianning Tian; Qihua Xu; Bingling Liao
Journal:  J Clin Lab Anal       Date:  2022-06-13       Impact factor: 3.124

2.  Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis.

Authors:  Tianyu Lin; Yi Dai; Xinli Guo; Wenchao Chen; Jiangang Zhao; Liping Cao; Zhengrong Wu
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

3.  Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.

Authors:  Jinpeng Yuan; Dongming Guo; Xinxin Li; Juntian Chen
Journal:  BMC Cancer       Date:  2020-05-19       Impact factor: 4.430

4.  Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.

Authors:  Nan Gao; Baoguo Ye
Journal:  Cancer Cell Int       Date:  2020-01-03       Impact factor: 5.722

Review 5.  Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer.

Authors:  Fei Long; Zhi Lin; Liang Li; Min Ma; Zhixing Lu; Liang Jing; Xiaorong Li; Changwei Lin
Journal:  Mol Cancer       Date:  2021-02-03       Impact factor: 27.401

6.  Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis.

Authors:  Weitong Zhang; Zhenfen Wang; Guohao Cai; Ping Huang
Journal:  Cancer Manag Res       Date:  2021-03-23       Impact factor: 3.989

Review 7.  Roles of circular RNAs in colorectal cancer.

Authors:  Mingying Zhang; Shubin Wang
Journal:  Oncol Lett       Date:  2021-06-10       Impact factor: 2.967

Review 8.  Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.

Authors:  Athina A Kyriazi; Efstathios Papiris; Konstantinos Kitsos Kalyvianakis; George Sakellaris; Stavroula Baritaki
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

Review 9.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

10.  Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.

Authors:  Ye Yao; Xiaoqin Li; Lihua Cheng; Xiuhua Wu; Bobo Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.